ACRS Aclaris Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$4,39
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,7452-Wochen-Tief
$6,6052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$614M
P/E (TTM)
-7.6
EPS (TTM)
$-0.58
Umsatz (TTM)
$8M
Ihre Abzeichen
52W-Spanne
$2–$7
Analystenbewertung
STRONG BUY
Kursziel
$10
P/E
-7.6
ROE
-59.1%
Nettogewinnmarge
-921.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ACRS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.39
Marktkapitalisierung (MRQ)
$614M
P/E (TTM)
-7.6
EPS (TTM)
$-0.58
Umsatz (TTM)
$8M
ROE (TTM)
-59.1%
52W-Spanne
$2–$7
ACRS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$8M2017-12-31 → 2025-12-31
EPS$-0.532019-12-31 → 2025-12-31
Freier Cashflow$-47M2016-12-31 → 2025-12-31
Nettogewinnmarge-921.5%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ACRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -7.65-Jahres-Durchschnitt ≈-5.8 | ≈-5.8 | · | · | |
| P/S (TTM) | 74.75-Jahres-Durchschnitt ≈46.0 | ≈46.0 | 6.3 | Überbewertet | |
| K/B (MRQ) | 4.95-Jahres-Durchschnitt ≈3.1 | ≈3.1 | 3.8 | Überbewertet | |
| Kurs / FCF (TTM) | -9.95-Jahres-Durchschnitt ≈-10.8 | ≈-10.8 | · | · | |
| Kurs / Cashflow (TTM) | -9.95-Jahres-Durchschnitt ≈-10.9 | ≈-10.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 5.15-Jahres-Durchschnitt ≈3.2 | ≈3.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ACRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -1050.2%5-Jahres-Durchschnitt ≈-734.9% | ≈-734.9% | -5.3% | Schwach | |
| EBITDA-Marge (TTM) | -1045.0%5-Jahres-Durchschnitt ≈-729.1% | ≈-729.1% | -1.8% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -829.6%5-Jahres-Durchschnitt ≈-691.1% | ≈-691.1% | -6.8% | Schwach | |
| Nettogewinnmarge (TTM) | -921.5%5-Jahres-Durchschnitt ≈-690.9% | ≈-690.9% | -15.6% | Schwach | |
| ROA (TTM) | -41.1%5-Jahres-Durchschnitt ≈-45.5% | ≈-45.5% | -22.7% | Schwach | |
| ROE (TTM) | -59.1%5-Jahres-Durchschnitt ≈-57.9% | ≈-57.9% | 51.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ACRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.55-Jahres-Durchschnitt ≈6.2 | ≈6.2 | 4.3 | Unterdurchschnittlich | |
| Quick Ratio | 0.75-Jahres-Durchschnitt ≈1.2 | ≈1.2 | 2.6 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ACRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -58.2%5-Jahres-Durchschnitt ≈50.2% | ≈50.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -35.9%5-Jahres-Durchschnitt ≈24.5% | ≈24.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 3.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ACRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.5 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$113.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
4.5%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.15 | $-0.16 | 8.1% |
| 31. März 2026 | Mai 12, 2026 | $-0.15 | $-0.16 | 6.8% |
| 31. Dezember 2025 | $-0.16 | $-0.15 | -4.6% | |
| 30. September 2025 | $-0.12 | $-0.14 | 12.9% | |
| 30. Juni 2025 | $-0.13 | $-0.14 | 4.1% | |
| 31. März 2025 | $-0.12 | $-0.12 | -0.08% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Cost of Revenue | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $4M | $1M | |
| Gross Profit | · | · | · | · | · | · | · | $3M | $476.0K | |
| R&D Expense | $53M | $34M | $98M | $78M | $44M | $29M | $64M | $61M | $36M | |
| SG&A Expense | $22M | $22M | $32M | $25M | $24M | $21M | $28M | $26M | $19M | |
| Operating Expenses | $84M | $161M | $129M | $120M | $96M | $57M | $115M | $91M | $56M | |
| Operating Income | $-76M | $-142M | $-97M | $-90M | $-90M | $-51M | $-111M | $-85M | $-54M | |
| Interest Income | $8M | $8M | $9M | · | · | · | · | · | · | |
| Other Non-op | $11M | $10M | $9M | $3M | $-1M | $-424.0K | $-2M | $3M | $2M | |
| Pretax Income | $-65M | $-132M | $-89M | $-87M | $-91M | $-51M | $-114M | $-82M | $-70M | |
| Income Tax | · | · | $-367.0K | · | · | $-182.0K | · | · | $-2M | |
| Net Income | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| EPS (Basic) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| EPS (Diluted) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| Shares (Basic) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| Shares (Diluted) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| EBITDA | $-76M | $-141M | $-96M | $-89M | $-89M | $-50M | $-105M | $-134M | $-72M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $40M | $45M | $27M | $22M | $34M | $168M | $20M | |
| Receivables | · | $318.0K | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |
| Inventory | · | · | · | · | · | · | $0 | $791.0K | · | |
| Prepaid Expense | · | $12M | $9M | $13M | $13M | $3M | $3M | $5M | $6M | |
| Current Assets | $96M | $126M | $129M | $232M | $205M | $57M | $84M | $179M | $200M | |
| PP&E (Net) | $761.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $6M | $6M | $5M | $5M | $4M | $5M | $4M | $3M | |
| Accum. Depreciation | · | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $480.0K | |
| Goodwill | · | · | · | · | · | · | · | $19M | $19M | |
| Intangibles | · | · | $269.0K | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $3M | $3M | $4M | $3M | $4M | $5M | $5M | $332.0K | $279.0K | |
| Total Assets | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Accounts Payable | $13M | $5M | $9M | $10M | $10M | $5M | $10M | $12M | $8M | |
| Accrued Liabilities | $9M | $20M | $19M | $9M | $10M | $6M | $8M | $8M | $5M | |
| Current Liabilities | $29M | $32M | $31M | $22M | $23M | $15M | $22M | $27M | $13M | |
| Capital Leases | $2M | $2M | $3M | $2M | $2M | $3M | $4M | · | · | |
| Deferred Tax | · | · | · | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K | |
| Other Non-current Liabilities | $2M | $4M | $3M | $2M | $2M | $3M | $4M | $476.0K | $558.0K | |
| Total Liabilities | $57M | $65M | $40M | $57M | $54M | $33M | $28M | $60M | $18M | |
| Long-term Debt | · | · | · | · | · | $11M | · | $30M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $1.07B | $1.06B | $928M | $881M | $793M | $542M | $524M | $507M | $385M | |
| Retained Earnings | $-968M | $-903M | $-771M | $-682M | $-595M | $-505M | $-454M | $-292M | $-159M | |
| AOCI | $610.0K | $97.0K | $-106.0K | $-897.0K | $-224.0K | $-94.0K | $-66.0K | $-69.0K | $-246.0K | |
| Stockholders' Equity | $103M | $156M | $157M | $198M | $197M | $38M | $70M | $215M | $225M | |
| Liabilities + Equity | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Shares Outstanding | 120,499,433 | 107,850,124 | 70,894,889 | 66,688,647 | 61,228,446 | 45,109,314 | 41,485,638 | 41,210,725 | 30,856,505 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1M | $6M | $2M | $402.0K | |
| Stock-based Comp | $12M | $11M | $21M | $15M | $14M | $11M | $16M | $20M | $14M | |
| Amort. of Intangibles | · | · | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $31.0K | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | |
| Other Non-cash | $5M | $100M | $-11M | $4M | $24M | $-149.0K | $42M | $10M | $-972.0K | |
| Operating Cash Flow | $-47M | $-20M | $-78M | $-68M | $-52M | $-39M | $-96M | $-101M | $-55M | |
| CapEx | $111.0K | $121.0K | $1M | $605.0K | $308.0K | $453.0K | $2M | $1M | $1M | |
| Investing Cash Flow | $48M | $-70M | $46M | $13M | $-168M | $6M | $106M | $9M | $-56M | |
| Financing Cash Flow | $-6M | $75M | $27M | $73M | $225M | $18M | $-30M | $128M | $100M | |
| Net Change in Cash | $-5M | $-15M | $-5M | $18M | $5M | $-14M | $-21M | $37M | $-10M | |
| Free Cash Flow | $-47M | $-20M | $-80M | $-68M | $-52M | $-39M | $-98M | $-102M | $-56M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 32.1% | 28.3% | |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | |
| Net Margin | -829.6% | -705.5% | -283.2% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | |
| Pretax Margin | -829.6% | -705.5% | -284.3% | -292.1% | -1344.0% | -792.0% | -3817.2% | -1315.4% | -4180.2% | |
| EBITDA Margin | -970.1% | -753.9% | -308.8% | -299.3% | -1313.4% | -765.0% | -2475.7% | -1323.3% | -4279.3% | |
| ROA | -34.1% | -63.2% | -39.1% | -34.4% | -56.4% | -60.3% | -86.3% | -51.1% | -32.7% | |
| ROE | -55.3% | -92.5% | -56.5% | -41.6% | -43.9% | -130.1% | -207.9% | -73.5% | -34.7% | |
| ROIC | · | · | -61.7% | · | · | -134.8% | · | · | -31.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 | 3.9 | 3.7 | 6.6 | 15.7 | |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 | 1.5 | 3.4 | 6.3 | 1.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 10.3 | 17.3 | · | |
| Receivables Turnover | · | 60.8 | 79.9 | 53.8 | 9.7 | 8.8 | 6.7 | 3.8 | 7.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.86 | $1.44 | $2.22 | $2.96 | $3.22 | $0.83 | $1.69 | $5.22 | $7.31 | |
| Revenue / Share | $0.06 | $0.24 | $0.45 | $0.46 | $0.12 | · | · | · | · | |
| Cash Flow / Share | $-0.38 | $-0.26 | $-1.12 | $-1.04 | $-0.92 | · | · | · | · | |
| Cash / Share | $0.17 | $0.23 | $0.56 | $0.68 | $0.45 | $0.49 | $1.81 | $4.08 | $0.66 | |
| EPS (TTM) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | · | · | · | · | |
| Revenue CAGR 3Y | -35.9% | 40.4% | 68.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Net Income TTM | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| Market Cap | $363M | $267M | $74M | $1.05B | $890M | $292M | $78M | $305M | $760M | |
| P/E | -5.7 | -1.5 | -0.8 | -11.8 | -9.1 | -5.4 | -0.5 | · | · | |
| P/S | 46.3 | 14.3 | 2.4 | 35.3 | 131.7 | 45.0 | 18.5 | 49.5 | 451.8 | |
| P/B | 3.5 | 1.7 | 0.5 | 5.3 | 4.5 | 7.8 | 1.1 | 1.4 | 3.4 | |
| P / Tangible Book | 3.5 | 1.7 | 0.5 | 5.5 | 4.7 | 9.6 | · | · | · | |
| P / Cash Flow | -7.7 | -13.3 | -1.0 | -15.5 | -17.1 | -7.6 | -0.8 | -3.0 | -13.9 | |
| P / FCF | -7.7 | -13.2 | -0.9 | -15.4 | -17.0 | -7.5 | -0.8 | -3.0 | -13.6 | |
| Earnings Yield | -17.6% | -69.0% | -121.0% | -8.4% | -11.0% | -18.6% | -206.3% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $3M | $2M | $1M | $9M | $4M | $3M | $2M | $18M | $9M | $2M | $3M | $8M | $19M | |
| Cost of Revenue | $218.0K | $395.0K | $532.0K | $538.0K | $515.0K | $506.0K | $705.0K | $654.0K | $624.0K | $809.0K | $725.0K | $848.0K | $1M | $808.0K | $877.0K | $923.0K | |
| R&D Expense | $18M | $16M | $17M | $13M | $11M | $12M | $9M | $6M | $9M | $10M | $27M | $24M | $25M | $23M | $21M | $24M | |
| SG&A Expense | $6M | $7M | $6M | $5M | $5M | $6M | $5M | $6M | $5M | $7M | $8M | $7M | $8M | $9M | $7M | $6M | |
| Operating Expenses | $26M | $24M | $24M | $20M | $20M | $20M | $109M | $15M | $16M | $21M | $22M | $41M | $34M | $32M | $37M | $40M | |
| Operating Income | $-24M | $-22M | $-23M | $-17M | $-18M | $-18M | $-100M | $-10M | $-13M | $-19M | $-4M | $-32M | $-32M | $-30M | $-29M | $-21M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | |
| Other Non-op | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $922.0K | |
| Pretax Income | · | · | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | · | · | · | · | · | · | |
| Net Income | $-22M | $-20M | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | $-1M | $-29M | $-30M | $-28M | $-28M | $-20M | |
| EPS (Basic) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| EPS (Diluted) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| Shares (Basic) | 142,736,848 | 128,810,050 | · | 122,619,311 | 122,580,967 | 122,390,303 | · | 71,381,731 | 71,291,400 | 71,074,858 | · | 70,807,934 | 70,633,528 | 66,872,778 | · | 66,675,337 | |
| Shares (Diluted) | 142,736,848 | 128,810,050 | · | 122,619,311 | 122,580,967 | 122,390,303 | · | 71,381,731 | 71,291,400 | 71,074,858 | · | 70,807,934 | 70,633,528 | 66,872,778 | · | 66,675,337 | |
| EBITDA | $-24M | $-22M | · | $-17M | $-18M | $-18M | · | $-10M | $-13M | $-19M | · | $-32M | $-32M | $-30M | · | $-21M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $29M | $20M | $25M | $25M | $30M | $25M | $48M | $23M | $36M | $40M | $39M | $31M | $45M | $45M | $62M | |
| Receivables | · | · | · | · | $194.0K | $250.0K | · | $343.0K | $325.0K | $373.0K | $298.0K | $346.0K | $431.0K | $686.0K | $484.0K | $597.0K | |
| Prepaid Expense | · | · | · | · | $4M | $3M | · | $4M | $6M | $7M | $9M | $20M | $13M | $13M | $13M | $8M | |
| Current Assets | $98M | $110M | $96M | $101M | $104M | $109M | $126M | $132M | $118M | $135M | $129M | $123M | $133M | $184M | $232M | $257M | |
| PP&E (Net) | $664.0K | $750.0K | $761.0K | $811.0K | $868.0K | $942.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | $6M | $6M | $6M | · | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Accum. Depreciation | · | · | · | $5M | $5M | $5M | · | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Accounts Payable | $16M | $15M | $13M | $9M | $9M | $6M | $5M | $8M | $7M | $11M | $9M | $10M | $11M | $8M | $10M | $8M | |
| Accrued Liabilities | $6M | $6M | $9M | $10M | $11M | $9M | $20M | $5M | $6M | $7M | $19M | $15M | $9M | $7M | $9M | $9M | |
| Current Liabilities | $28M | $27M | $29M | $26M | $27M | $22M | $32M | $19M | $16M | $20M | $31M | $27M | $23M | $18M | $22M | $20M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | |
| Other Non-current Liabilities | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $55M | $55M | $57M | $55M | $57M | $54M | $65M | $52M | $27M | $32M | $40M | $62M | $56M | $53M | $57M | $48M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.13B | $1.13B | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B | $936M | $933M | $930M | $928M | $927M | $921M | $888M | $881M | $876M | |
| Retained Earnings | $-1.01B | $-988M | $-968M | $-948M | $-933M | $-918M | $-903M | $-806M | $-799M | $-788M | $-771M | $-769M | $-740M | $-710M | $-682M | $-655M | |
| AOCI | $-304.0K | $22.0K | $610.0K | $597.0K | $482.0K | $434.0K | $97.0K | $427.0K | $-463.0K | $-364.0K | $-106.0K | $-1M | $-1M | $-354.0K | $-897.0K | $-1M | |
| Stockholders' Equity | $125M | $144M | $103M | $120M | $132M | $144M | $156M | $130M | $134M | $142M | $157M | $156M | $180M | $177M | $198M | $220M | |
| Liabilities + Equity | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Shares Outstanding | 139,824,273 | 139,652,849 | 120,499,433 | 108,342,592 | 108,328,794 | 108,265,529 | 107,850,124 | 71,417,513 | 71,332,825 | 71,248,017 | 70,894,889 | 70,818,954 | 70,769,702 | 67,206,025 | 66,688,647 | 66,679,641 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $107.0K | $102.0K | $102.0K | $110.0K | $114.0K | $128.0K | $143.0K | $179.0K | $242.0K | $243.0K | $228.0K | $219.0K | $218.0K | $198.0K | $190.0K | $193.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $1M | $6M | $7M | $7M | $5M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $19.0K | $19.0K | $19.0K | $18.0K | $19.0K | |
| Restructuring | · | · | · | · | · | · | · | $32.0K | $98.0K | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-2M | · | · | · | $-6M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-20M | $-18M | $-13M | $-11M | $-10M | $-13M | $-9M | $22M | $-12M | $-21M | $-7M | $-25M | $-21M | $-26M | $-19M | $-8M | |
| CapEx | $58.0K | $13.0K | $24.0K | $23.0K | $21.0K | $43.0K | $0 | $0 | $-14.0K | $135.0K | $441.0K | $84.0K | $231.0K | $553.0K | $105.0K | $150.0K | |
| Investing Cash Flow | $10M | $-31M | $10M | $14M | $5M | $19M | $-89M | $3M | $-674.0K | $17M | $8M | $33M | $-20M | $26M | $3M | $1M | |
| Financing Cash Flow | $91.0K | $58M | $-3M | $-3M | $-9.0K | $-275.0K | $75M | $22.0K | $-11.0K | $-55.0K | $49.0K | $-87.0K | · | · | $37.0K | $-11.0K | |
| Net Change in Cash | $-9M | $9M | $-5M | $-146.0K | $-5M | $6M | $-23M | $25M | $-13M | $-4M | $838.0K | $8M | $-14M | $-555.0K | $-16M | $-7M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-21M | · | · | · | $-27M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1487.9% | -1111.8% | · | -519.8% | -1035.9% | -1242.9% | · | -240.9% | -464.7% | -789.4% | · | -340.2% | -1702.2% | -1183.5% | · | -109.8% | |
| Net Margin | -1320.1% | -993.2% | · | -443.0% | -868.3% | -1036.8% | · | -174.6% | -397.2% | -706.5% | · | -315.2% | -1582.1% | -1113.9% | · | -104.9% | |
| Pretax Margin | · | · | · | -443.0% | -868.3% | -1036.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1487.9% | -1106.7% | · | -519.8% | -1035.9% | -1234.1% | · | -240.9% | -464.7% | -779.3% | · | -340.2% | -1702.2% | -1175.6% | · | -109.8% | |
| ROA | -11.7% | -10.0% | · | -8.2% | -8.8% | -8.1% | · | -3.8% | -5.5% | -8.4% | · | -12.0% | -11.5% | -12.3% | · | -7.5% | |
| ROE | -16.8% | -13.8% | · | -11.7% | -11.6% | -10.5% | · | -5.3% | -7.0% | -10.6% | · | -15.6% | -14.2% | -15.8% | · | -9.1% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.0 | · | 3.9 | 3.9 | 5.1 | · | 7.0 | 7.5 | 6.7 | · | 4.5 | 5.8 | 10.1 | · | 13.0 | |
| Quick Ratio | 0.7 | 1.0 | · | 1.0 | 1.0 | 1.4 | · | 2.6 | 1.5 | 1.8 | · | 1.4 | 1.4 | 2.5 | · | 3.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 6.8 | 4.7 | · | 12.6 | 7.3 | 4.5 | · | 19.7 | 3.5 | 3.8 | · | 27.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.89 | $1.03 | · | $1.11 | $1.22 | $1.33 | · | $1.82 | $1.88 | $1.99 | · | $2.21 | $2.54 | $2.63 | · | $3.30 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.03 | $0.01 | $0.01 | · | $0.06 | $0.04 | $0.03 | · | $0.13 | $0.03 | $0.04 | · | $0.29 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.11 | · | · | · | $-0.29 | · | · | · | $-0.39 | · | · | |
| Cash / Share | $0.14 | $0.21 | · | $0.23 | $0.23 | $0.28 | · | $0.67 | $0.32 | $0.50 | · | $0.55 | $0.44 | $0.67 | · | $0.92 | |
| EPS (TTM) | $-0.58 | $-0.56 | · | $-1.58 | $-1.57 | $-1.59 | · | $-0.52 | $-0.82 | $-1.09 | · | $-1.66 | $-1.55 | $-1.44 | · | $-1.26 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $8M | · | $16M | $17M | $18M | · | $27M | $32M | $31M | · | $21M | $31M | $31M | · | $24M | |
| Net Income TTM | $-76M | $-70M | · | $-142M | $-135M | $-130M | · | $-37M | $-59M | $-77M | · | $-115M | $-105M | $-96M | · | $-82M | |
| Market Cap | $740M | $524M | · | $206M | $154M | $166M | · | $82M | $78M | $88M | · | $485M | $734M | $544M | · | $1.05B | |
| P/E | -9.1 | -6.7 | · | -1.2 | -0.9 | -1.0 | · | -2.2 | -1.3 | -1.1 | · | -4.1 | -6.7 | -5.6 | · | -12.5 | |
| P/S | 90.0 | 62.6 | · | 13.1 | 9.2 | 9.3 | · | 3.0 | 2.5 | 2.8 | · | 22.6 | 23.5 | 17.6 | · | 44.7 | |
| P/B | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.1 | 4.1 | 3.1 | · | 4.8 | |
| P / Tangible Book | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.2 | 4.2 | 3.2 | · | 4.9 | |
| P / Cash Flow | · | -28.9 | · | · | · | -12.7 | · | · | · | -4.2 | · | · | · | -20.6 | · | · | |
| Earnings Yield | -11.0% | -14.9% | · | -83.2% | -110.6% | -103.9% | · | -45.2% | -74.6% | -87.9% | · | -24.2% | -14.9% | -17.8% | · | -8.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $8M | $19M | $31M | $30M | $7M |
| Betriebsgewinnmarge % | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% |
| Nettoergebnis | $-65M | $-132M | $-88M | $-87M | $-91M |
| Verwässerte EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-47M | $-20M | $-80M | $-68M | $-52M |
Institutionelle Eigentümer (13F) 159 Einreicher · $647.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
159
Gehaltener Wert
$647.0M
Neue Positionen
29
Geschlossene Positionen
14
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 29 (-7 vs. Vorquartal) | 14 (0 vs. Vorquartal) | 66 (+25 vs. Vorquartal) | 35 (-6 vs. Vorquartal) | +10.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $67.304.808 | 12.723.026 | 10,40% | Aktien |
| BML Capital Management, LLC | $63.347.750 | 11.975.000 | 9,79% | Aktien |
| BlackRock, Inc. | $53.095.772 | 10.037.008 | 8,21% | Aktien |
| Deep Track Capital, LP | $49.435.050 | 9.345.000 | 7,64% | Aktien |
| Vivo Capital, LLC | $35.414.630 | 6.694.637 | 5,47% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.776.511 | 5.817.866 | 4,76% | Aktien |
| Frazier Life Sciences Management, L.P. | $26.055.228 | 4.925.374 | 4,03% | Aktien |
| Rock Springs Capital Management LP | $22.908.514 | 4.330.532 | 3,54% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $21.535.590 | 4.071.000 | 3,33% | Aktien |
| Decheng Capital LLC | $21.380.783 | 4.041.736 | 3,30% | Aktien |
| VANGUARD GROUP INC | $19.571.260 | 6.502.080 | 3,02% | Aktien |
| STATE STREET CORP | $17.220.749 | 3.255.340 | 2,66% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $16.879.468 | 3.190.058 | 2,61% | Aktien |
| BRAIDWELL LP | $11.333.021 | 2.142.348 | 1,75% | Aktien |
| Balyasny Asset Management L.P. | $10.704.156 | 2.023.470 | 1,65% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $10.296.890 | 1.946.482 | 1,59% | Aktien |
| Kalehua Capital Management LLC | $9.693.211 | 1.832.365 | 1,50% | Aktien |
| CITADEL ADVISORS LLC | $9.321.408 | 1.762.081 | 1,44% | Aktien |
| Jones Hill Capital LP | $9.307.713 | 1.759.492 | 1,44% | Aktien |
| Palo Alto Investors LP | $8.535.045 | 1.613.430 | 1,32% | Aktien |
| Woodline Partners LP | $8.522.476 | 1.611.054 | 1,32% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.753.738 | 1.465.735 | 1,20% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $7.174.044 | 1.356.152 | 1,11% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $6.400.297 | 1.209.886 | 0,99% | Aktien |
| MPM BIOIMPACT LLC | $5.514.650 | 1.042.467 | 0,85% | Aktien |
| DEUTSCHE BANK AG\ | $5.506.652 | 1.040.955 | 0,85% | Aktien |
| NORTHERN TRUST CORP | $5.283.456 | 998.763 | 0,82% | Aktien |
| KOTLER KEVIN | $5.134.846 | 1.705.929 | 0,79% | Aktien |
| Aldebaran Capital, LLC | $4.955.307 | 936.731 | 0,77% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.798.945 | 907.173 | 0,74% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $4.324.739 | 817.531 | 0,67% | Aktien |
| Three Bridge Wealth Advisors, LLC | $3.781.414 | 714.823 | 0,58% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.222.447 | 609.158 | 0,50% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.771.405 | 523.895 | 0,43% | Aktien |
| CITADEL ADVISORS LLC | $2.756.090 | 521.000 | 0,43% | Kaufoption |
| DIMENSIONAL FUND ADVISORS LP | $2.714.467 | 513.840 | 0,42% | Aktien |
| JPMORGAN CHASE & CO | $2.354.200 | 468.964 | 0,36% | Aktien |
| Aisling Capital Management LP | $2.298.267 | 434.455 | 0,36% | Aktien |
| ORBIMED ADVISORS LLC | $2.229.735 | 421.500 | 0,34% | Aktien |
| D. E. Shaw & Co., Inc. | $2.192.700 | 414.499 | 0,34% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.182.384 | 412.549 | 0,34% | Aktien |
| Tetragon Partners GP Ltd | $2.116.000 | 400.000 | 0,33% | Aktien |
| Russell Investments Group, Ltd. | $1.931.139 | 365.055 | 0,30% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.830.647 | 346.058 | 0,28% | Aktien |
| FMR LLC | $1.660.267 | 313.850 | 0,26% | Aktien |
| Bank of New York Mellon Corp | $1.494.949 | 282.599 | 0,23% | Aktien |
| Nuveen, LLC | $1.472.758 | 278.404 | 0,23% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.457.982 | 275.611 | 0,23% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.415.064 | 267.498 | 0,22% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $1.363.101 | 257.675 | 0,21% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| M. Arkin (1999) Ltd., Moshe Arkin ×3 Einreichungen | 19. Dezember 2019 | · | Erste Einreichung | · | SEC |
| Vivo Ventures VII, LLC ×6 Einreichungen | 14. Februar 2019 | · | Erste Einreichung | · | SEC |
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C. (“SM VIII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 Einreichungen | 14. Februar 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| Vivo Ventures VII, LLC FEIN, Vivo Ventures Fund VII, L.P. FEIN, Vivo Ventures VII Affiliates Fund, L.P. FEIN | 20. Oktober 2015 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 15 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Neal Walker | CEO | 2. Februar 2026 A | 1.543.886 | 0 | 0 | $0 |
| Douglas J. Manion | Pres and CEO | 1. Januar 2024 M | 41.813 | 0 | 0 | $0 |
| Kevin Balthaser | Chief Financial Officer | 1. März 2026 M | 187.453 | 0 | 0 | $0 |
| Frank Ruffo | Chief Financial Officer | 10. März 2022 S | 201.883 | 0 | 0 | $0 |
| Hugh M. Davis | President and COO | 2. Februar 2026 A | 45.425 | 0 | 0 | $0 |
| Roland Wilhelm Kolbeck | Chief Scientific Officer | 1. August 2026 M | 23.990 | 0 | 0 | $0 |
| Jesse Wayne Hall | Chief Medical Officer | 1. Mai 2026 M | 27.045 | 0 | 0 | $0 |
| James Loerop | Chief Business Officer | 2. Februar 2026 A | 192.260 | 0 | 0 | $0 |
| Joseph Monahan | Chief Scientific Officer | 1. März 2025 M | 265.662 | 0 | 0 | $0 |
| Gail Cawkwell | Chief Medical Officer | 1. Juli 2023 M | 9.593 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Chief Legal Officer | 3. Januar 2022 M | 160.214 | 0 | 0 | $0 |
| David N. Gordon | Chief Medical Officer | 13. Juli 2021 S | 147.447 | 0 | 0 | $0 |
| Stuart Shanler | Chief Scientific Officer | 1. März 2019 A | 272.047 | 0 | 0 | $0 |
| Brett Fair | Chief Commercial Officer | 1. Februar 2019 M | 10.582 | 0 | 0 | $0 |
| Christopher Powala | Chief Reg & Develop Officer | 1. Februar 2019 M | 141.729 | 0 | 0 | $0 |
| William D. Humphries | Direktor | 5. Juni 2026 M | 45.105 | 0 | 0 | $0 |
| Christopher P. Molineaux | Direktor | 5. Juni 2026 M | 69.536 | 0 | 0 | $0 |
| Anand Mehra | Direktor | 5. Juni 2026 M | 726.403 | 0 | 0 | $0 |
| Maxine Gowen | Direktor | 5. Juni 2026 M | 33.334 | 0 | 0 | $0 |
| Vincent Milano | Direktor | 5. Juni 2026 M | 28.896 | 0 | 0 | $0 |
| Andrew N Schiff | Direktor | 5. Juni 2026 M | 25.540 | 0 | 0 | $0 |
| Bryan M. Reasons | Direktor | 1. Juni 2024 M | 28.732 | 0 | 0 | $0 |
| Andrew Kenneth William Powell | Direktor | 1. Juni 2024 M | 33.523 | 0 | 0 | $0 |
| Stephen A. Tullman | Direktor | 4. Oktober 2018 P | 177.457 | 0 | 0 | $0 |
| Rick Bierly | Direktor | 15. Juni 2017 A | · | 0 | 0 | $0 |
| Albert Cha | Direktor | 29. Juni 2016 A | 4.191.397 | 0 | 0 | $0 |
| Leonard Braden Michael | · | 23. April 2026 S | 13.950.000 | 0 | 1 | $-1.359.000 |
| FMR LLC | · | 21. August 2017 | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 26 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,65% | 26.010 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,62% | 568.298 SH | 2. Oktober 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,38% | 19.831 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,15% | 402.862 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 325.402 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,05% | 847.703 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 10.412 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,04% | 960.785 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 109.271 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 147.460 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 3.078.262 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 682.643 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 56.601 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 8.179 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.449.139 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14.250 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 324.191 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 95.349 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 275.693 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 39.838 SH | 10. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 26.214 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 404 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 21.533 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.243.349 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.978 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 166.559 SH | 11. September 2026 | Täglich |
ACRS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$10.00
+127,8%
8 44,4%
Starker Kauf
8 44,4%
Kauf
2 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-10-04Mittelwert-Ziel $10.50 +139,2%
Jetzt
Aktueller Preis $4.39
Tief$4.00
Mittelwert$10.50
Hoch$16.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| SGP | · | · | · | · | 50.0% | · |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | · |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| CTNM | · | -5.3 | · | · | -27.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026